Status and phase
Conditions
Treatments
About
Safety evaluation of Intra-Coronary Administration of MCRcI® stem cells in Patients with Diffuse Coronary Artery Disease.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
40 participants in 3 patient groups
Loading...
Central trial contact
Jackson TK Liu, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal